Skip to main content
Log in

Adalimumab improves HRQOL in AS

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Davis Jr JC, Revicki D, van der Heijde DMF, Rentz AM, Wong RL, Kupper H, Luo MP.Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study. Arthritis and Rheumatism 57: 1050-1057, No. 6, 15 Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab improves HRQOL in AS. Pharmacoecon. Outcomes News 538, 10 (2007). https://doi.org/10.2165/00151234-200705380-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705380-00023

Keywords

Navigation